Seer appoints Anthony Bazarko as chief commercial officer

Seer, Inc. Class A

Seer, Inc. Class A

SEER

0.00
  • Seer appointed Anthony Bazarko as chief commercial officer to lead Sales, Marketing, Customer Experience.
  • Bazarko most recently served as president and CEO of Biologos from 2022 to 2025, overseeing strategic and operational changes through its acquisition by Ampersand Capital Partners.
  • He previously was chief commercial officer at Specific Diagnostics, where he built global go-to-market strategy leading to an acquisition by bioMérieux.
  • Earlier roles include vice president of commercial development for Americas at Danaher’s Leica Biosystems, plus senior leadership posts at Roche Diagnostics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seer Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605040700PRIMZONEFULLFEED9712132) on May 04, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.